A 49-year-old man had an abnormal shadow on chest X-ray. Enhanced chest computed tomography (CT) revealed an 8-cm diameter right lung mass invading the right chest wall, with a tumor thrombus extending from the superior pulmonary vein into the left atrium. Transesophageal echocardiography confirmed that the tumor adjoined the side wall of the atrium. Endobronchial and CT-guided needle biopsy demonstrated a low-grade carcinoma or small cell carcinoma. Operative findings through left atriotomy under cardiopulmonary bypass showed no tumor invasion of the atrium wall, but protrusion through the pulmonary vein. Frozen sections revealed a non-small cell carcinoma. We performed right upper lobectomy with parietal pleura and mediastinal lymph node dissection after detachment of cardiopulmonary bypass. Pathological examination demonstrated a large-cell neuroendocrine carcinoma p-T4N0M0, stage IIIA. The patient recovered without postoperative complications and tolerated two cycles of adjuvant chemotherapy. He was doing well without symptoms of recurrence 42 months after surgery.
Introduction
Approximately 8% -10% of lung cancers invade the heart, especially the left atrium [1] , which can lead to widespread systemic embolization and/or outflow tract obstruction. Treatment of these cases is therefore always warranted. However, these T4 patients are generally considered to be inoperable [2] , and treatment including radical resection presents a therapeutic challenge. Nevertheless, improvements in operative and perioperative capabilities, including cardiopul-Open Journal of Thoracic Surgery monary bypass, dedicated cardiothoracic anesthesia, and treatments for postoperative complications, mean that extended resections for T4N0/1 non-small cell lung cancer (NSCLC) with partial resection of the left atrium have been performed with reasonable postoperative morbidity and mortality [3] . Timely surgical intervention can be life-saving by preventing sudden cardiac arrest due to intracardiac extension of the lung cancer [4] .
We present a case of pulmonary large cell neuroendocrine carcinoma complicated with a left atrial tumor thrombus. After careful preoperative evaluation of the tumor thrombus by ultrasonic cardiography, the patient was treated successfully by right upper lobectomy and atriotomy with cardiopulmonary bypass. 
Case Report

Discussion
Lung cancer is one of the most common causes of metastatic cardiac tumor, and several cases of intra-cardiac extension via the pulmonary vein have been reported. If left untreated, patients may die from sudden cardiac arrest due to cardia inflow obstruction or massive tumor embolization in the major organs [5] [6], which is one of the most serious complications. Schreffler et al. reported a case of simultaneous acute bilateral lower limb ischemia, and bilateral renal, splenic, and cerebral infarction as a result of multiple emboli originating from invasion of a primary lung malignancy in the left atrium [7] . Given the risk of systemic embolization, mitral obstruction, or sudden death as a result of tumor thrombus detachment, comprehensive preoperative preparation and meticulous intraoperative surgery need to be emphasized to ensure complete resection of the tumor thrombus.
Because of the catastrophic complications of intra-atrial tumors, aggressive treatment is typically pursued regardless of the patient's overall prognosis. Although several studies have demonstrated potentially beneficial palliative effects of stereotactic radiotherapy in patients with stage IV lung cancer invading the left atrium [8] [9] , surgical resection remains the historical gold standard treatment. The 5-year survival rate among 44 patients receiving left atrium resection was 22%, including six cases without distant metastasis who experienced long-term survival over 5 years [10] . In a recent review of 18 previous cases (1995) (1996) (1997) (1998) (1999) (2000) (2001) (2002) (2003) (2004) (2005) (2006) (2007) (2008) (2009) (2010) (2011) (2012) (2013) PV1-3
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LA Open Journal of Thoracic Surgery [8] , surgery combined with chemotherapy was the most common treatment for this condition, with survival times ranging from 4 -17 months.
In the current case, we performed surgical resection followed by adjuvant chemotherapy. In another review of nine papers reporting on the postoperative outcomes of patients with primary lung cancer involving the left atrium [11] , although the advantages of surgery after induction therapy have not been established for T4 lung cancer involving the left atrium, 25% (0% -60%) of patients received induction treatment. Importantly, pneumonectomy was selected in 81% (63% -100%) of patients and pathological N2 disease was contained in 32% (17% -53%). Because recurrences in distant organs were considered in these patients, adjuvant chemotherapy may also play a positive role in the treatment of advanced lung cancer, and pneumonectomy should be avoided to preserve chemotherapy tolerance. Although cardiopulmonary bypass should generally be avoided during the treatment of malignant tumors because of the risk of intraoperative tumor cell dissemination [12] , extended lobectomy with left atrium reconstruction under cardiopulmonary bypass, avoiding pneumonectomy, might be appropriate together with adjuvant therapy in patients with left atrium extension NSCLC.
